0001410384-20-000143.txt : 20200902 0001410384-20-000143.hdr.sgml : 20200902 20200902163837 ACCESSION NUMBER: 0001410384-20-000143 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200831 FILED AS OF DATE: 20200902 DATE AS OF CHANGE: 20200902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Flake Matthew P CENTRAL INDEX KEY: 0001597592 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36350 FILM NUMBER: 201157335 MAIL ADDRESS: STREET 1: 13785 RESEARCH BLVD. STREET 2: SUITE 150 CITY: AUSTIN STATE: TX ZIP: 78750 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Q2 Holdings, Inc. CENTRAL INDEX KEY: 0001410384 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 202706637 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13785 RESEARCH BOULEVARD STREET 2: SUITE 150 CITY: Austin STATE: TX ZIP: 78750 BUSINESS PHONE: 512-275-0072 MAIL ADDRESS: STREET 1: 13785 RESEARCH BOULEVARD STREET 2: SUITE 150 CITY: Austin STATE: TX ZIP: 78750 FORMER COMPANY: FORMER CONFORMED NAME: CBG Holdings, Inc. DATE OF NAME CHANGE: 20120103 FORMER COMPANY: FORMER CONFORMED NAME: CBG Holdings Inc DATE OF NAME CHANGE: 20070821 4 1 wf-form4_159907910252893.xml FORM 4 X0306 4 2020-08-31 0 0001410384 Q2 Holdings, Inc. QTWO 0001597592 Flake Matthew P 13785 RESEARCH BLVD. SUITE 150 AUSTIN TX 78750 1 1 0 0 President and CEO Common Stock 2020-08-31 4 M 0 10000 20.19 A 279541 D Common Stock 2020-08-31 4 S 0 10000 97.78 D 269541 D Employee Stock Option (right to buy) 20.19 2020-08-31 4 M 0 10000 0 D 2016-02-20 2022-02-20 Common Stock 10000.0 57333 D Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.18 to $98.615 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This option grant vested as to 1/4 of the total option grant on February 20, 2016, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests. M. Scott Kerr, as attorney-in-fact 2020-09-02